<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Heart Views</journal-id><journal-id journal-id-type="iso-abbrev">Heart Views</journal-id><journal-id journal-id-type="publisher-id">HV</journal-id><journal-title-group><journal-title>Heart Views : The Official Journal of the Gulf Heart Association</journal-title></journal-title-group><issn pub-type="ppub">1995-705X</issn><issn pub-type="epub">0976-5123</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27326348</article-id><article-id pub-id-type="pmc">4590189</article-id><article-id pub-id-type="publisher-id">HV-16-85</article-id><article-id pub-id-type="doi">10.4103/1995-705X.164462</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Angiographic Findings after Supplementation with <italic>Heracleum persicum</italic> Extract: Results of a Randomized Controlled Trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Panahi</surname><given-names>Yunes</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Pishgoo</surname><given-names>Bahram</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Sahebkar</surname><given-names>Amirhossein</given-names></name><xref ref-type="aff" rid="aff3">2</xref><xref ref-type="aff" rid="aff4">3</xref><xref ref-type="corresp" rid="cor1"/></contrib></contrib-group><aff id="aff1">Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran</aff><aff id="aff2"><label>1</label>Department of Cardiology, Cardiovascular Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran</aff><aff id="aff3"><label>2</label>Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran</aff><aff id="aff4"><label>3</label>Metabolic Research Centre, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, Australia</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Amirhossein Sahebkar, Department of Medical Biotechnology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, P.O. Box: 91779-48564, Iran. E-mail: <email xlink:href="sahebkara@mums.ac.ir">sahebkara@mums.ac.ir</email>; <email xlink:href="amir_saheb2000@yahoo.com">amir_saheb2000@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jul-Sep</season><year>2015</year></pub-date><volume>16</volume><issue>3</issue><fpage>85</fpage><lpage>87</lpage><permissions><copyright-statement>Copyright: &#x000a9; Gulf Heart Association 2015.</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions><abstract><sec id="st1"><title>Background:</title><p><italic>Heracleum persicum</italic> is a common dietary spice with several traditional medicinal properties important for cardiovascular health including antioxidant, hypolipidemic, and anti-inflammatory effects. This study explored the effects of supplementation with <italic>H. persicum</italic> fruit on the angiographic findings of patients with minimal coronary artery disease (CAD).</p></sec><sec id="st2"><title>Methods:</title><p>Subjects who were diagnosed with &#x0003c;50% stenosis in any of their coronary arteries by angiography were selected for this trial and randomly assigned to <italic>H. persicum</italic> hydroalcoholic fruit extract (<italic>n</italic> = 15; 300 mg/day) or placebo (<italic>n</italic> = 12) for 6 months. At the end of the trial, participants underwent a second coronary angiography in order to evaluate the progression of their disease.</p></sec><sec id="st3"><title>Results:</title><p>Posttrial angiography did not reveal any improvement in the number of stenosed vessels after consumption of <italic>H. persicum</italic> extract versus placebo (<italic>P</italic> &#x0003e; 0.05). Similarly, there was no significant difference between the study groups in terms of disease progression and chest pain score (<italic>P</italic> &#x0003e; 0.05).</p></sec><sec id="st4"><title>Conclusions:</title><p>The present results do not support any clinically significant benefit of supplementation with <italic>H. persicum</italic> extract on the angiographic findings of in patients with minimal CAD.</p></sec></abstract><kwd-group><kwd>Angiography</kwd><kwd><italic>Heracleum persicum</italic></kwd><kwd>herbal pharmacotherapy</kwd><kwd>ischaemic heart disease</kwd><kwd>randomized controlled trial</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>INTRODUCTION</title><p>Coronary artery disease (CAD) is the most common type of cardiovascular disease and results in the reduction of cardiac blood flow because of atherosclerotic plaque formation and subsequent arterial narrowing.[<xref rid="ref1" ref-type="bibr">1</xref>] CAD accounts for a considerable burden of mortality as well as tremendous health care cost.[<xref rid="ref2" ref-type="bibr">2</xref>] Numerous evidence from epidemiological surveys has shown an inverse association between consumption of diets rich in vegetables and fruits, and the occurrence of CAD and its complications.[<xref rid="ref3" ref-type="bibr">3</xref>] Plants contain a multitude of bioactive phytochemicals that can synergistically modify several cardiovascular risk factors including inflammation, dyslipidemia, hypertension, insulin resistance, and adiposity.[<xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref5" ref-type="bibr">5</xref><xref rid="ref6" ref-type="bibr">6</xref>]</p><p><italic>Heracleum persicum</italic> (Persian hogweed) is a perennial herb belonging to the family Apiaceae. This plant is endemic to Iran and is known with the vernacular name &#x0201c;Golpar.&#x0201d; Fruits of <italic>H. persicum</italic> are commonly consumed in the Persian cuisine as a dietary spice.</p><p>H. Persicum fruits are reputed in Iranian traditional medicine for treating various ailments. In addition, modern pharmacological research has unveiled different activities of <italic>H. persicum</italic>, including anti-inflammatory,[<xref rid="ref7" ref-type="bibr">7</xref>] antioxidant,[<xref rid="ref8" ref-type="bibr">8</xref>] and lipid-modifying effects.[<xref rid="ref9" ref-type="bibr">9</xref>] These activities are important for the prevention of atherosclerosis and promotion of cardiovascular health. However, no study has yet evaluated the efficacy of supplementation with <italic>H. persicum</italic> in CAD patients. The present pilot study aimed to investigate this issue in subjects with minimal CAD.</p></sec><sec sec-type="methods" id="sec1-2"><title>METHODS</title><p>This study was designed as a randomized, double-blind, and placebo-controlled trial. Included subjects were selected from those with symptoms of stable angina pectoris who were referred to the Cardiology Clinic at the Baqiyatallah Hospital (Tehran, Iran) for coronary angiography. Subjects had myocardial ischemia according to the findings of the exercise test, thallium single photon emission computed tomography or dobutamin stress echocardiography. Coronary angiography was performed using routine procedures and angiograms were interpreted offline by a blinded cardiologist.</p><p>For this trial, only subjects with minimal CAD (defined as &#x0003c;50% stenosis in any of the coronary arteries) were selected. Candidates of coronary artery bypass grafting and coronary angioplasty, as well as those subjects with &#x0003e;50% reduction of coronary artery diameter, unstable angina, acute coronary syndrome, systemic diseases and malignancies were excluded from the trial. Eligible subjects (<italic>n</italic> = 27) were randomly allocated to receive <italic>H. persicum</italic> hydroalcoholic extract (<italic>n</italic> = 15; 300 mg/day) or matching placebo (<italic>n</italic> = 12) for a period of 6 months. All patients were receiving standard of care treatments for controlling comorbidities such as dyslipidemia and hypertension. At the end of the trial, participants underwent a second coronary angiography in order to evaluate the progression of their disease.</p></sec><sec sec-type="results" id="sec1-3"><title>RESULTS</title><p>The groups were comparable at baseline regarding age, gender, anthropometric parameters, ejection fraction, the number of diseased vessels, history of cardiovascular disease and drug therapy (<italic>P</italic> &#x0003e; 0.05). Similarly, there was no significant difference in the frequencies of smoking, dyslipidemia and hypertension between the study groups (<italic>P</italic> &#x0003e; 0.05) [<xref ref-type="table" rid="T1">Table 1</xref>].</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Baseline characteristics of the study groups</p></caption><graphic xlink:href="HV-16-85-g001"/></table-wrap><p>Posttrial angiography did not reveal any improvement in the number of stenosed vessels after consumption of <italic>H. persicum</italic> extract versus placebo, apart from a significant difference in the number of subjects with normal angiographic findings in the left circumflex artery (<italic>P</italic> &#x0003c; 0.001), and a borderline difference in the number of subjects with normal posterior descending artery (<italic>P</italic> = 0.070). There was no significant difference between the study groups in terms of disease progression and chest pain score (<italic>P</italic> &#x0003e; 0.05) [<xref ref-type="table" rid="T2">Table 2</xref>].</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Frequency of coronary arteries with normal angiographic finding at baseline and study end</p></caption><graphic xlink:href="HV-16-85-g002"/></table-wrap></sec><sec sec-type="conclusions" id="sec1-4"><title>CONCLUSIONS</title><p>The above results do not support any clinically significant benefit of supplementation with <italic>H. persicum</italic> extract in patients with minimal CAD. Previous studies have shown that <italic>H. persicum</italic> is rich in phytochemicals such as flavonoids and furanocoumarins,[<xref rid="ref10" ref-type="bibr">10</xref><xref rid="ref11" ref-type="bibr">11</xref>] and have been shown to possess anti-atherosclerotic and cardioprotective properties.[<xref rid="ref12" ref-type="bibr">12</xref>] Furthermore, our previous trial demonstrated the efficacy of <italic>H. persicum</italic> extract as adjunct to low-dose atorvastatin in lowering serum total cholesterol and low-density lipoprotein cholesterol concentrations,[<xref rid="ref9" ref-type="bibr">9</xref>] but the impact of this plant extract on the formation and progression of atherosclerotic plaques has not yet been reported.</p><p>In light of the present results, <italic>H. persicum</italic> extract is unlikely to have any significant plaque-regressing effect because of the futility of this extract in reducing luminal narrowing of coronary arteries. In spite of this negative finding, it must be noted that the present trial investigated the impact of short-term supplementation with <italic>H. persicum</italic> extract and the number studied was small. That long-term consumption of this extract can improve angiographic findings remains open to question, and merits further investigation.</p></sec></body><back><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> This study was financially supported by the Clinical Trial Research Center, Tehran, Iran.</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kattainen</surname><given-names>A</given-names></name><name><surname>Salomaa</surname><given-names>V</given-names></name><name><surname>H&#x000e4;rk&#x000e4;nen</surname><given-names>T</given-names></name><name><surname>Jula</surname><given-names>A</given-names></name><name><surname>Kaaja</surname><given-names>R</given-names></name><name><surname>Kes&#x000e4;niemi</surname><given-names>YA</given-names></name><etal/></person-group><article-title>Coronary heart disease: From a disease of middle-aged men in the late 1970s to a disease of elderly women in the 2000s</article-title><source>Eur Heart J</source><year>2006</year><volume>27</volume><fpage>296</fpage><lpage>301</lpage><pub-id pub-id-type="pmid">16284204</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Go</surname><given-names>AS</given-names></name><name><surname>Mozaffarian</surname><given-names>D</given-names></name><name><surname>Roger</surname><given-names>VL</given-names></name><name><surname>Benjamin</surname><given-names>EJ</given-names></name><name><surname>Berry</surname><given-names>JD</given-names></name><name><surname>Blaha</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Heart disease and stroke statistics-2014 update: A report from the American Heart Association</article-title><source>Circulation</source><year>2014</year><volume>129</volume><fpage>e28</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">24352519</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Genkinger</surname><given-names>JM</given-names></name><name><surname>Platz</surname><given-names>EA</given-names></name><name><surname>Hoffman</surname><given-names>SC</given-names></name><name><surname>Comstock</surname><given-names>GW</given-names></name><name><surname>Helzlsouer</surname><given-names>KJ</given-names></name></person-group><article-title>Fruit, vegetable, and antioxidant intake and all-cause, cancer, and cardiovascular disease mortality in a community-dwelling population in Washington County, Maryland</article-title><source>Am J Epidemiol</source><year>2004</year><volume>160</volume><fpage>1223</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">15583375</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>RH</given-names></name></person-group><article-title>Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals</article-title><source>Am J Clin Nutr</source><year>2003</year><volume>78</volume><issue>3 Suppl</issue><fpage>517S</fpage><lpage>20S</lpage><pub-id pub-id-type="pmid">12936943</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahebkar</surname><given-names>A</given-names></name><name><surname>Chew</surname><given-names>GT</given-names></name><name><surname>Watts</surname><given-names>G</given-names></name></person-group><article-title>F. Recent advances in pharmacotherapy for hypertriglyceridemia</article-title><source>Progress in Lipid Research</source><year>2014</year><volume>56</volume><fpage>47</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">25083925</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Sun</surname><given-names>M</given-names></name><name><surname>Lv</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name></person-group><source>Herbal drugs against cardiovascular disease: Traditional medicine and modern development (2015) Drug Discovery Today</source><comment>DOI: 10.1016/j.drudis.2015.04.009</comment></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hajhashemi</surname><given-names>V</given-names></name><name><surname>Sajjadi</surname><given-names>SE</given-names></name><name><surname>Heshmati</surname><given-names>M</given-names></name></person-group><article-title>Anti-inflammatory and analgesic properties of <italic>Heracleum persicum</italic> essential oil and hydroalcoholic extract in animal models</article-title><source>J Ethnopharmacol</source><year>2009</year><volume>124</volume><fpage>475</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">19467316</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Firuzi</surname><given-names>O</given-names></name><name><surname>Asadollahi</surname><given-names>M</given-names></name><name><surname>Gholami</surname><given-names>M</given-names></name><name><surname>Javidnia</surname><given-names>K</given-names></name></person-group><article-title>Composition and biological activities of essential oils from four <italic>Heracleum species</italic></article-title><source>Food Chem</source><year>2010</year><volume>122</volume><fpage>117</fpage><lpage>22</lpage></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panahi</surname><given-names>Y</given-names></name><name><surname>Pishgoo</surname><given-names>B</given-names></name><name><surname>Beiraghdar</surname><given-names>F</given-names></name><name><surname>Araghi</surname><given-names>ZM</given-names></name><name><surname>Sahebkar</surname><given-names>A</given-names></name><name><surname>Abolhasani</surname><given-names>E</given-names></name></person-group><article-title>Results of a randomized, open-label, clinical trial investigating the effects of supplementation with <italic>Heracleum persicum</italic> extract as an adjunctive therapy for dyslipidemia</article-title><source>ScientificWorldJournal</source><year>2011</year><volume>11</volume><fpage>592</fpage><lpage>601</lpage><pub-id pub-id-type="pmid">21403978</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghodsi</surname><given-names>B</given-names></name></person-group><article-title>Flavonoids of three <italic>Heracleum species</italic></article-title><source>Bull Trav Soc Pharm Lyon</source><year>1976</year><volume>20</volume><fpage>3</fpage><lpage>8</lpage></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merijanian</surname><given-names>A</given-names></name><name><surname>Colasurdo</surname><given-names>I</given-names></name><name><surname>Samtak</surname><given-names>P</given-names></name><name><surname>Ullrichand</surname><given-names>J</given-names></name><name><surname>Spagnuolo</surname><given-names>J</given-names></name></person-group><article-title>The furanocoumarins of <italic>Heracleum persicum</italic> L</article-title><source>Rev Latinoam Quim</source><year>1980</year><volume>11</volume><fpage>51</fpage><lpage>3</lpage></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siasos</surname><given-names>G</given-names></name><name><surname>Tousoulis</surname><given-names>D</given-names></name><name><surname>Tsigkou</surname><given-names>V</given-names></name><name><surname>Kokkou</surname><given-names>E</given-names></name><name><surname>Oikonomou</surname><given-names>E</given-names></name><name><surname>Vavuranakis</surname><given-names>M</given-names></name><etal/></person-group><article-title>Flavonoids in atherosclerosis: An overview of their mechanisms of action</article-title><source>Curr Med Chem</source><year>2013</year><volume>20</volume><fpage>2641</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">23627935</pub-id></element-citation></ref></ref-list></back></article>